Key Takeaways
- Shares of RKLB have declined approximately 30% from their late-May peak, currently hovering near $107.98
- First-quarter revenue reached an all-time high of $200.35 million, representing 63.4% growth year-over-year and surpassing analyst forecasts
- The company will be added to the Nasdaq-100 index on June 22, potentially driving increased institutional investment
- Institutional investors now control 71.78% of shares, with Capital Impact Advisors increasing holdings by 47.5%
- Analyst consensus reflects a “Moderate Buy” rating with an average target price of $102.76
Since SpaceX announced its highly anticipated IPO, Rocket Lab’s stock has experienced significant turbulence, plummeting nearly 30% from its late-May zenith of approximately $151.00. Trading commenced Thursday at $107.98, maintaining a position above the 50-day moving average of $104.00 while remaining considerably distant from recent peaks.
The stock price decline stands in stark contrast to operational performance. First-quarter revenue registered at $200.35 million, establishing a new quarterly benchmark with a remarkable 63.4% increase compared to the previous year. This performance exceeded Wall Street’s consensus estimate of $189.65 million.
Gross profit margins also achieved a company record at 38.2% during Q1, signaling enhanced operational efficiency as the organization expands. With a backlog totaling $2.2 billion, the firm enjoys substantial revenue predictability moving forward.
Executive leadership has projected another record-breaking quarter for Q2, extending a pattern that indicates Rocket Lab has entered a sustainable expansion phase rather than experiencing temporary momentum.
Government Defense Work Expands Revenue Streams
Rocket Lab is diversifying beyond its core launch business into the defense sector. In 2024, the company won a substantial $515 million contract from the Space Development Agency (SDA) for satellite manufacturing, establishing itself as a primary contractor for U.S. government space programs.
Additionally, the firm secured a $30 million agreement with Anduril Industries to deploy its HASTE vehicle for hypersonic testing missions from Virginia’s Launch Complex 2. These government partnerships are strategically expanding revenue sources beyond traditional commercial small-satellite deployments.
Rocket Lab’s Electron launch vehicle maintains its position as the globe’s most active small-lift rocket, executing 10–15 missions annually. Within this market segment, its primary competitor is Galactic Energy with their Ceres-1 platform.
In a significant commercial milestone announced last month, the company secured its largest block-purchase agreement to date — five Neutron rocket launches contracted before the vehicle’s maiden flight.
Index Addition Driving Institutional Activity
Rocket Lab’s addition to the Nasdaq-100 index takes effect on June 22. This development represents a potential catalyst, as index membership typically triggers automatic purchases from passive investment vehicles that replicate the index composition.
Capital Impact Advisors expanded its position by 47.5% during the fourth quarter, acquiring an additional 145,741 shares to reach a total holding of 452,728 units. Institutional ownership across all investors currently represents 71.78% of outstanding shares.
Regarding insider transactions, SVP Arjun Kampani divested 23,804 shares at $147.43 on May 28, while insider Marvin Bradford Clevenger sold 3,500 shares at $146.67 during the same trading session. Company insiders have collectively sold $66.9 million in stock over the previous 90-day period.
Valuation metrics present a challenge for prospective investors. RKLB currently trades at a forward price-to-sales ratio approaching 68x, representing a premium exceeding 3,500% above the sector median. Such elevated multiples are generally associated with high-margin technology platforms rather than capital-intensive aerospace manufacturers operating at 38% gross margins.
The Neutron medium-lift launch vehicle, which appears substantially reflected in current market pricing, has yet to complete its inaugural mission. A recent propellant tank testing anomaly has delayed the first launch until Q4 2026, maintaining execution uncertainty.
Following first-quarter results, TD Cowen and Needham both elevated their price objectives to $120 while maintaining Buy recommendations. KGI Securities commenced coverage on June 11 with a Neutral stance and $105 target. The Wall Street consensus target currently stands at $102.76.


